Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet

[1]  C. Everett-Grueter,et al.  A Novel Glucagon Receptor Antagonist, NNC 25-0926, Blunts Hepatic Glucose Production in the Conscious Dog , 2007, Journal of Pharmacology and Experimental Therapeutics.

[2]  K. Fosgerau,et al.  Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function , 2006, Diabetes.

[3]  V. Ding,et al.  Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists. , 2005, Bioorganic & medicinal chemistry letters.

[4]  R. Rizza,et al.  Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. , 2005, Diabetes.

[5]  M. Michael,et al.  Glucagon as a target for the treatment of Type 2 diabetes , 2005, Expert opinion on therapeutic targets.

[6]  B. Ahrén,et al.  The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. , 2004, Diabetes.

[7]  D. Moller,et al.  A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects. , 2004, Diabetes.

[8]  J. Fenyk-Melody,et al.  Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists. , 2004, European journal of pharmacology.

[9]  R. Perfetti,et al.  Role of caspases in the regulation of apoptotic pancreatic islet beta‐cells death , 2004, Journal of cellular physiology.

[10]  N. Porksen,et al.  Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. , 2004, The Journal of clinical investigation.

[11]  F. Sundler,et al.  β-Cell-targeted Overexpression of Phosphodiesterase 3B in Mice Causes Impaired Insulin Secretion, Glucose Intolerance, and Deranged Islet Morphology* , 2004, Journal of Biological Chemistry.

[12]  M. Kuhar,et al.  Cocaine- and Amphetamine-regulated Transcript (CART) Is Expressed in Several Islet Cell Types During Rat Development , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  B. Monia,et al.  Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. , 2004, Diabetes.

[14]  B. Ahrén,et al.  Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance , 1996, Diabetologia.

[15]  J. Holst,et al.  Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats , 1994, Diabetologia.

[16]  Bei B. Zhang,et al.  Glucagon and regulation of glucose metabolism. , 2003, American journal of physiology. Endocrinology and metabolism.

[17]  J. Holst,et al.  Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Kuki,et al.  Human glucagon receptor antagonists based on alkylidene hydrazides. , 2002, Bioorganic & medicinal chemistry letters.

[19]  J. Stock,et al.  Glycemic control in mice with targeted disruption of the glucagon receptor gene. , 2002, Biochemical and biophysical research communications.

[20]  K. Petersen,et al.  Effects of a novel glucagon receptor antagonist (Bay 27–9955) on glucagon-stimulated glucose production in humans , 2001, Diabetologia.

[21]  K Thomaseth,et al.  Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. , 2001, American journal of physiology. Endocrinology and metabolism.

[22]  D. Porte,et al.  beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. , 2001, Diabetes.

[23]  D. Pipeleers,et al.  Glucagon receptors on human islet cells contribute to glucose competence of insulin release , 2000, Diabetologia.

[24]  B. Ahrén,et al.  Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women , 2000, Diabetologia.

[25]  R. Rizza,et al.  Impact of lack of suppression of glucagon on glucose tolerance in humans. , 1999, American journal of physiology. Endocrinology and metabolism.

[26]  P. Halban,et al.  Role of the Prohormone Convertase PC3 in the Processing of Proglucagon to Glucagon-like Peptide 1* , 1997, The Journal of Biological Chemistry.

[27]  P. Halban,et al.  Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon , 1997, FEBS letters.

[28]  F. Sundler,et al.  Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. , 1997, Metabolism: clinical and experimental.

[29]  I. Svendsen,et al.  Evidence for a Major Role for Glucagon in Regulation of Plasma Glucose in Conscious, Nondiabetic, and Alloxan-Induced Diabetic Rabbits , 1996, Diabetes.

[30]  V. Hruby,et al.  Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists. , 1996, Endocrinology.

[31]  J. Holst,et al.  Role of glucagon in maintenance of euglycemia in fed and fasted rats. , 1995, The American journal of physiology.

[32]  R N Bergman,et al.  The Contribution of Insulin-Dependent and Insulin-Independent Glucose Uptake to Intravenous Glucose Tolerance in Healthy Human Subjects , 1994, Diabetes.

[33]  K. Jungermann,et al.  Relative contribution of glycogenolysis and gluconeogenesis to basal, glucagon- and nerve stimulation-dependent glucose output in the perfused liver from fed and fasted rats. , 1990, Biochemistry international.

[34]  H. Mashiba,et al.  Effect of Glucagon on Glucose Output from Bivascularly Perfused Rat Liver , 1989, Experimental and clinical endocrinology.

[35]  A. Baron,et al.  Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics , 1987, Diabetes.

[36]  A. Golay,et al.  Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. , 1987, The Journal of clinical endocrinology and metabolism.

[37]  V. Hruby,et al.  Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. , 1982, Science.

[38]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[39]  G WhittakerP,et al.  共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値 , 1980 .

[40]  R. Unger,et al.  Role of glucagon in the pathogenesis of diabetes: the status of the controversy. , 1978, Metabolism: clinical and experimental.

[41]  S. Oikawa,et al.  Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus. , 1978, The Journal of clinical endocrinology and metabolism.

[42]  A. Cherrington,et al.  Control of hepatic glucose output by glucagon and insulin in the intact dog. , 1978, Biochemical Society Symposium.

[43]  P. Bennett,et al.  Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians. , 1977, The Journal of clinical endocrinology and metabolism.

[44]  M. Lorenzi,et al.  Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. , 1975, JAMA.

[45]  L. Orci,et al.  Glucagon: role in the hyperglycemia of diabetes mellitus. , 1975, Science.

[46]  L. Orci,et al.  THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS , 1975, The Lancet.

[47]  W. A. Müller,et al.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. , 1970, The New England journal of medicine.